Evaluation of Pediatric eCART Implementation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 17
SponsorUniversity of Wisconsin, Madison
About this trial
This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pediatric eCART), a clinical decision support (CDS) tool that uses electronic health records (EHR) to identify patients with high risk for life threatening outcomes. Up to 30,000 encounters with pediatric patients will be assessed. Acceptability of the pediatric eCART intervention will also be measured from pediatric nurse clinicians.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All pediatric patients scored on pediatric eCART (or eligible for scoring on either algorithm in the pre-implementation period) will be screened for study eligibility.
Patients eligible for pediatric eCART scoring include pediatric (<18 years of age) patients
Inpatient locations
Disqualifiers
Patients who are ineligible for pediatric eCART scoring
Neonates and birth encounters will be excluded from the pediatric eCART study
UW Health nurses who interact with eCART during patient care
UW Health nurses no longer employed at UW Health
Trial design
Design model
Single group
Treatments tested in this trial
Pediatric eCART
DeviceIntegration of the pediatric version of electronic Cardiac Arrest Risk Triage as a clinical decision support tool within Epic for use by clinicians
Treatment groups
30,000 Participants
are divided into 1 treatment groupGroup A: Pediatric eCARTExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
In Hospital Mortality
Time frame
assessed through hospital stay (typically up to 5 days on average, but may be over 60 days)2
Intensive Care Unit (ICU) free days
Defined as the number of days patients were both alive and discharged from the ICU out of the first 28 days of hospitalization. Because death is biased toward fewer ICU days and is a competing outcome, patients who die prior to day 28 are assigned with 0 ICU-free days.
Time frame
up to 28 daysSecondary outcomes
1
Median 30-day Ventilator-Free Days
Time frame
assessed through hospital stay (typically up to 5 days on average, but may be over 60 days)2
Summary of Critical Events
Summary of critical events, including mechanical ventilation, vasoactive administration, or death, reported by participant count.
Time frame
assessed through hospital stay (typically up to 5 days on average, but may be over 60 days)3
Total Hospital Length of Stay (LOS)
Reported in days
Time frame
assessed through hospital stay (typically up to 5 days on average, but may be over 60 days)4
Number of ICU transfers
Time frame
assessed through hospital stay (typically up to 5 days on average, but may be over 60 days)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Wisconsin, Madison
Lead sponsor
AgileMD, Inc.
Collaborator
Source ClinicalTrials.gov